Heart Failure Implantable Secures $16M+ for CE Approval

Image credit: Robina Weermeijer via Unsplash

Swiss medtech, Berlin Heals has secured over $16 million (€10 million) to support its goal of securing European CE approval for its implantable electroceutical device for treating heart failure.

The Cardiac Microcurrent Therapy Device (C-MIC) delivers a constant, but minimal electrical current to a patient’s heart via two electrodes – the company touting promising outcomes from clinical trials demonstrating the potential for the technology to become the world’s first “near-curative heart failure therapy”.

The C-MIC device received Breakthrough Device Designation from the US Food and Drug Administration (FDA) in March 2021.

For more information, refer to the Berlin Heals website or check out this story from Medical Device Network.